Combating Malevolence

Whatever the entertainment and artistic merits of the movie "The Constant Gardener," released at the end of last month, the pharmaceutical industry could do without it.

Written byRichard Gallagher
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Whatever the entertainment and artistic merits of the movie "The Constant Gardener," released at the end of last month, the pharmaceutical industry could do without it. A bit of a departure for John Le Carré, the author of the book the movie is based on, it substitutes a villainous pharma industry for the KGB/CIA. Even KVH, the company's three-letter acronym – a sure sign of a bad guy – is retained. KVH has a problem: its tuberculosis drug has side effects that are preventing approval in the West, so it turns to Africa to try to iron out the kinks. Villagers serve as unwilling human guinea pigs, with appalling consequences. For my view of the movie, see http://media.the-scientist.com/blog/display/1/92.

The pharmaceutical industry is quickly becoming a pariah. We're not shy about criticizing drug companies in these pages, as we've noted the failure to publish negative clinical trial results and the excessive ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies